Literature DB >> 29261825

Age at Diagnosis as a Relative Contraindication for Intervention in Facial Nonmelanoma Skin Cancer.

Ruvi Chauhan1, Brook N Munger1, Michael W Chu2, Imtiaz Munshi3, Adam C Cohen2, William A Wooden2, Sunil S Tholpady2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29261825      PMCID： PMC5933388          DOI： 10.1001/jamasurg.2017.5073

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  4 in total

1.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

Authors:  Howard W Rogers; Martin A Weinstock; Ashlynne R Harris; Michael R Hinckley; Steven R Feldman; Alan B Fleischer; Brett M Coldiron
Journal:  Arch Dermatol       Date:  2010-03

2.  Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens.

Authors:  Susan M Swetter; Jennifer C Boldrick; Peterson Pierre; Patricia Wong; Barbara M Egbert
Journal:  J Cutan Pathol       Date:  2003-02       Impact factor: 1.587

3.  Surgical Excision of Non-Melanoma Skin Cancer in an Elderly Veteran's Affairs Population.

Authors:  C Malcolm M Stewart; Jared Garlick; Jaron Mcmullin; Faizi Siddiqi; Courtney Crombie; W Bradford Rockwell; Barbu Gociman
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-01-08

4.  No Residual Basal Cell Carcinoma after Excision for Biopsy-proven Tumor: Clinical and Medicolegal Implications.

Authors:  Raffi Gurunluoglu; Eddie Kubek; Jamie Arton; Adam Olsen; Michael Bronsert
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-01-06
  4 in total
  1 in total

1.  Functional status and survival in patients ≥85 years of age who have keratinocyte carcinoma: A retrospective cohort study.

Authors:  Niki B Vora; Karen L Connolly; Stephen Dusza; Anthony M Rossi; Kishwer S Nehal; Erica H Lee
Journal:  J Am Acad Dermatol       Date:  2020-04-19       Impact factor: 11.527
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.